###begin article-title 0
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
Prader-Willi and Angelman syndrome (PWS and AS) patients typically have an ~5 Mb deletion of human chromosome 15q11-q13, of opposite parental origin. A mouse model of PWS and AS has a transgenic insertion-deletion (TgPWS/TgAS) of chromosome 7B/C subsequent to paternal or maternal inheritance, respectively. In this study, we define the deletion endpoints and examine the impact on expression of flanking genes.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 376 385 376 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 512 519 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 695 701 693 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 786 793 784 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
Using molecular and cytological methods we demonstrate that 13 imprinted and 11 non-imprinted genes are included in the TgPWS/TgAS deletion. Normal expression levels were found in TgPWS brain for genes extending 9.1- or 5.6-Mb centromeric or telomeric of the deletion, respectively. Our molecular cytological studies map the proximal deletion breakpoint between the Luzp2 and Siglec-H loci, and we show that overall mRNA levels of Luzp2 in TgPWS and TgAS brain are significantly reduced by 17%. Intriguingly, 5' Chrna7 shows 1.7-fold decreased levels in TgPWS and TgAS brain whereas there is a >/=15-fold increase in expression in neonatal liver and spleen of these mouse models. By isolating a Chrna7-Tg fusion transcript from TgAS mice, we mapped the telomeric deletion breakpoint in Chrna7 intron 4.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 601 608 601 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 731 738 731 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 883 890 883 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Based on the extent of the deletion, TgPWS/TgAS mice are models for PWS/AS class I deletions. Other than for the first gene promoters immediately outside the deletion, since genes extending 5.6-9.1 Mb away from each end of the deletion show normal expression levels in TgPWS brain, this indicates that the transgene array does not induce silencing and there are no additional linked rearrangements. Using gene expression, non-coding conserved sequence (NCCS) and synteny data, we have genetically mapped a putative Luzp2 neuronal enhancer responsible for ~33% of allelic transcriptional activity. The Chrna7 results are explained by hypothesizing loss of an essential neuronal transcriptional enhancer required for ~80% of allelic Chrna7 promoter activity, while the Chrna7 promoter is upregulated in B lymphocytes by the transgene immunoglobulin enhancer. The mapping of a putative Chrna7 neuronal enhancer inside the deletion has significant implications for understanding the transcriptional regulation of this schizophrenia-susceptibility candidate gene.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 752 753 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 802 810 802 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1020 1021 1020 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1355 1361 1355 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBE3A </italic>
###xml 1367 1368 1367 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
###xml 944 952 <span type="species:ncbi:9606">patients</span>
Prader-Willi and Angelman syndrome (PWS and AS) are complex neurobehavioral disorders associated with loss of function of a cluster of differentially expressed imprinted genes in chromosome 15q11-q13 [1]. PWS is characterized by a neonatal stage of failure to thrive, hypotonia and respiratory distress followed by hyperphagia in early childhood with development of severe obesity, as well as short stature, hypogonadism, small hands and feet, mild to moderate mental retardation, and obsessive-compulsive behavior [2,3]. In contrast, AS patients have a more pronounced neurological disease including developmental delay, severe mental retardation with lack of speech, hyperactivity, seizures, aggressive behavior and excessive inappropriate laughter [2]. Most PWS and AS cases (~70%) are due to ~5 Mb de novo deletions spanning a 2 Mb imprinted domain and several adjacent non-imprinted genes [1]. There are two classes of deletions in PWS/AS patients, one from breakpoint 1 (BP1) to BP3 and the other from BP2 to BP3 [4]. Additionally, paternal or maternal uniparental disomy (pat or matUPD) explain 25% of PWS and 5% of AS cases, respectively, while 2-5% of PWS and AS cases result from imprinting defects (ID). In each mechanism, PWS arises from loss of ten paternally expressed loci, while AS arises from loss of function of the maternally expressed UBE3A gene [1].
###end p 9
###begin p 10
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ube3a </italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 454 460 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A,B</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 886 887 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 967 968 967 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 261 266 <span type="species:ncbi:10090">mouse</span>
###xml 419 424 <span type="species:ncbi:10090">mouse</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 638 643 <span type="species:ncbi:9606">human</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 807 812 <span type="species:ncbi:10090">mouse</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
Mouse models of PWS with either matUPD [5], an ID [6] or a paternally-inherited chromosome deletion [7] share a similar phenotype with failure to thrive, hypotonia and early postnatal lethality, modeling the first stage of the human syndrome [9,10]. Similarly, mouse models of AS have a patUPD [10], maternally-inherited chromosome deletion [7], or a maternal mutation of Ube3a [11,12]. In the transgenic (Tg) deletion mouse model, an Epstein Barr Virus LMP2A transgene integrated with ~80 copies into mouse chromosome 7B/C and created an ~5 Mb deletion of the mouse region homologous to the human PWS/AS genes (see Fig. 1A,B) [7]. As in human, the phenotype of the deletion mouse model depends on the parental origin: paternal or maternal inheritance of the Tg-deletion, respectively, results in the TgPWS mouse model characterized by severe neonatal hypoglycemia and early lethality [9] or in TgAS mice with a mild neurobehavioral phenotype and late onset obesity [7].
###end p 10
###begin p 11
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genetic and physical maps of mouse chromosome 7B/C</bold>
###xml 52 109 52 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) The mouse PWS/AS-homologous region and flanking genes</bold>
###xml 348 349 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 829 894 829 894 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) Human synteny for genes from the mouse chromosome 7B/C domain</bold>
###xml 1079 1154 1079 1154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) BAC contig across the TgPWS/TgAS centromeric deletion breakpoint region</bold>
###xml 1353 1354 1353 1354 <underline xmlns:xlink="http://www.w3.org/1999/xlink">N</underline>
###xml 1357 1358 1357 1358 <underline xmlns:xlink="http://www.w3.org/1999/xlink">C</underline>
###xml 1364 1365 1364 1365 <underline xmlns:xlink="http://www.w3.org/1999/xlink">C</underline>
###xml 1374 1375 1374 1375 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 1411 1418 1411 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit70</italic>
###xml 1438 1444 1438 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1452 1461 1452 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 1465 1473 1465 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5 </italic>
###xml 1483 1556 1483 1556 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) BAC contig across the TgPWS/TgAS telomeric deletion breakpoint region</bold>
###xml 1717 1724 1717 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1727 1736 1727 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2 </italic>
###xml 1740 1746 1740 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf13 </italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 833 838 <span type="species:ncbi:9606">Human</span>
###xml 866 871 <span type="species:ncbi:10090">mouse</span>
###xml 900 905 <span type="species:ncbi:9606">human</span>
###xml 948 953 <span type="species:ncbi:10090">mouse</span>
###xml 1072 1077 <span type="species:ncbi:9606">human</span>
Genetic and physical maps of mouse chromosome 7B/C. (A) The mouse PWS/AS-homologous region and flanking genes. Symbols are: circles, protein-coding genes; ovals, RNA-coding genes; black, paternally-expressed; grey, maternally-expressed; white, biparentally-expressed; line arrows, transcriptional orientation of genes; IC; imprinting center; plo1, p-locus-associated obesity; cp1, cleft palate 1; oca2, oculocutaneous albinism type II (p, pink-eyed dilution); jdf2, juvenile development and fertility 2; cen, centromere; tel, telomere; *, genes represented on the Gene chip MG_U74Av2 (see Table 1); #, genes analyzed by QRT-PCR; horizontal grey bar, extent of the TgPWS/TgAS ~5 Mb deletion. The first 3 genes and one more distant gene extending out from each of the centromeric and telomeric deletion breakpoints are also shown. (B) Human synteny for genes from the mouse chromosome 7B/C domain. The human chromosome locations for each orthologous mouse gene shown in (A) are given. Arrowheads represent rodent-specific gene duplications for which no ortholog is found in human. (C) BAC contig across the TgPWS/TgAS centromeric deletion breakpoint region. Symbols are: white boxes, exons; line arrows, transcriptional orientation of genes; white bars, BACs, and one "wgs" (whole genome shotgun) contig; grey bars, BACs used as FISH probes; black boxes, Non-Coding Conserved Sequences (NCCSs) in RP24-246A19; *, D7Mit70. The interval from Luzp2 through Siglec-H and Tubgcp5 is shown. (D) BAC contig across the TgPWS/TgAS telomeric deletion breakpoint region. Symbols are as for Fig 1C, except: black boxes, four intronless imprinted genes. The interval from the telomeric end of the 2 Mb imprinted gene domain through Chrna7 to Cezanne2 and Klf13 is shown.
###end p 11
###begin p 12
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 387 398 387 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn</italic>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 405 411 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Magel2</italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mkrn3</italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Herc2</italic>
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyfip1</italic>
###xml 595 604 595 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans </italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 946 955 946 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 959 965 959 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1011 1018 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1144 1150 1144 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1154 1161 1154 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 746 751 <span type="species:ncbi:10090">mouse</span>
Previous imprinted gene expression studies and fluorescence in situ hybridization (FISH) showed that the Tg insertion-deletion comprised all of the orthologs of PWS and AS imprinted genes and of several flanking non-imprinted genes [Fig. 1A; [7,13,14]]. In addition, brain microarray and quantitative gene expression analyses confirmed the loss of expression of several imprinted genes (Snurf-Snrpn, Ndn, Magel2, Mkrn3) and 50% reduced expression of two non-imprinted loci (Herc2, Cyfip1) in TgPWS mouse brain, and demonstrated that an unidentified non-imprinted locus within the deletion acted in trans to regulate a chromosome 18B3 gene expression domain [15]. To define the exact characteristics of the transgene insertion-deletion TgPWS/TgAS mouse model, we have now determined the extent of the deletion and the effect of the Tg-insertion and deletion on expression of flanking genes. We delineated the deletion breakpoint positions between Siglec-H and Luzp2 at the centromeric end and within intron 4 of Chrna7 at the telomeric end. Most importantly, we describe tissue-specific positional effects of the Tg insertion and/or deletion on Luzp2 and Chrna7 expression which are likely due to the presence or absence of specific enhancer elements.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
FISH refines the TgPWS/TgAS deletion extent and identifies a centromeric breakpoint
###end title 14
###begin p 15
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C,D</xref>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyr </italic>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
We used FISH with BAC probes flanking the mouse PWS/AS-homologous domain in chromosome 7B/C (Fig. 1C,D) to define the centromeric and telomeric extent of the TgPWS/TgAS deletion. To identify both chromosome 7 homologues in our FISH experiments using splenocytes from TgAS mice or fibroblasts from TgPWS mice, we co-hybridized BAC RP22-434N7 from the Tyr gene locus at position 74.6 Mb (chromosome 7E1), which is intact in TgPWS and TgAS mice (Fig. 2, and data not shown) [7].
###end p 15
###begin p 16
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fluorescence <italic>in situ </italic>hybridization (FISH) maps the TgAS centromeric and telomeric deletion extent</bold>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyr</italic>
###xml 365 384 365 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) BAC RP24-354P8 </bold>
###xml 414 423 414 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 427 435 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5 </italic>
###xml 529 544 529 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) RP23-256L9 </bold>
###xml 554 556 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 610 626 610 626 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) RP24-426A19 </bold>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 858 874 858 874 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) RP23-199N11 </bold>
###xml 908 914 908 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3 </italic>
###xml 918 925 918 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 954 967 954 967 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) RP23-506 </bold>
###xml 975 981 975 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf13 </italic>
###xml 1019 1033 1019 1033 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) RP23-16A4 </bold>
###xml 1055 1062 1055 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
Fluorescence in situ hybridization (FISH) maps the TgAS centromeric and telomeric deletion extent. In each case, BAC RP22-434N7 from the chromosome 7 Tyrosinase (Tyr) locus (74.6 Mb; 44.0 cM) was hybridized as a control and is shown as a red signal. All chromosome 7B/C BACs used as probes are shown as green signals while chromosomes are stained with DAPI (blue). (A) BAC RP24-354P8 spanning the region including Siglec-H and Tubgcp5 shows a single-chromosome 7 signal indicating the deletion of this locus in TgAS splenocytes. (B) RP23-256L9 spans the p locus (exons 10-24) and is also deleted in TgAS mice. (C) RP24-426A19 spans the region 3' of Luzp2 and detects a weak signal on one chromosome 7 homologue, suggesting partial deletion and detection of the centromeric breakpoint in the mutant mice. The two insets show the images for individual probes. (D) RP23-199N11 covers part of the region between Frat3 and Chrna7 and is deleted in TgAS mice. (E) RP23-506 for the Klf13 locus is intact in the deletion mice. (F) RP23-16A4 spans all 10 exons of Chrna7 and shows an apparently intact signal in TgAS mice.
###end p 16
###begin p 17
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D7Mit70</italic>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5 </italic>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 207 209 207 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Herc2</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nipa1</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
At the centromeric end of the deletion, BAC RP24-354P8 spanning the Siglec-H-D7Mit70-Tubgcp5 region (43.3 Mb, Fig. 1C) is deleted from one chromosome 7 in TgAS mice (Fig. 2A). Additionally, BACs RP23-256L9 (p gene exons 10-24; 44 Mb) and RP23-195C6 (Herc2-Nipa1; 43.6 Mb) are within the TgPWS/TgAS deletion (Fig. 1A, Fig. 2B, and data not shown) as expected based on their map position. In contrast, BAC RP24-426A19 from ~50 kb 3' of Luzp2 (42.9 Mb; Fig. 1C) shows a weak positive signal on one chromosome 7 homologue in TgAS mice (Fig. 2C), suggesting a partial deletion and detection of the centromeric breakpoint in TgAS mice.
###end p 17
###begin p 18
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3</italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mkrn3</italic>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Magel2 </italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3 </italic>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf13 </italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 479 488 479 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2 </italic>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 597 603 597 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rlbp1 </italic>
###xml 636 642 636 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il-16 </italic>
###xml 745 752 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 1178 1184 1178 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
At the telomeric end of the deletion, BAC RP23-266F22 (49.4 Mb; Fig. 1D) spanning four mouse PWS-region imprinted genes, including Frat3, Mkrn3, Magel2 and Ndn, was previously found to be deleted in TgPWS mice [13]. Extending telomeric from Frat3 towards Chrna7 (Fig. 1D), BACs RP23-100P8, RP23-199N11 and RP23-140J4 were all deleted in TgPWS mice (Fig. 2D, and data not shown). In contrast, BACs RP23-5O6 from the Klf13 region (50.9 Mb; Fig. 1D, Fig. 2E) and RP24-215K5 from 5' Cezanne2 (Fig. 1D; data not shown) were intact in TgPWS/TgAS mice. Two other BACs mapping more telomeric, RP23-76F18 (Rlbp1 locus, 66.4 Mb) and RP23-441D12 (Il-16 locus, 70.8 Mb), were also intact in TgPWS mice (data not shown). Intriguingly, BAC RP23-16A4 spanning Chrna7 (50.1 Mb; Fig. 1D) appears based on hybridization signal intensity to be fully intact in TgPWS mice (Fig. 2F). Nevertheless, molecular data described below indicate that about half of 16A4 is deleted in TgPWS/TgAS mice; it is likely that these ostensibly contradictory data are explained by the relative concentration of unique and repetitive DNA sequences at the telomeric and centromeric ends of BAC 16A4 (5' and 3' ends of Chrna7, respectively) as well as the difficulty in quantifying FISH signals.
###end p 18
###begin title 19
Microarray and QRT-PCR analyses further define the TgPWS/TgAS deletion extent
###end title 19
###begin p 20
###xml 276 287 276 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn</italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Magel2 </italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mkrn3</italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 405 411 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Herc2 </italic>
###xml 415 422 415 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyfip1 </italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 928 935 928 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5</italic>
###xml 1007 1014 1007 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5</italic>
###xml 1150 1151 1150 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1166 1170 1166 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gas2</italic>
###xml 1172 1179 1172 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hrmt1l3</italic>
###xml 1181 1185 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F8</italic>
###xml 1187 1192 1187 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ptpn5</italic>
###xml 1198 1204 1198 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tsg101</italic>
###xml 1286 1287 1286 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1389 1394 1389 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3</italic>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1448 1453 1448 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf13</italic>
###xml 1455 1463 1455 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BB128963</italic>
###xml 1465 1469 1465 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcee</italic>
###xml 1471 1476 1471 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apba2</italic>
###xml 1478 1482 1478 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tjp1</italic>
###xml 1484 1490 1484 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snrp2a</italic>
###xml 1492 1495 1492 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H47</italic>
###xml 1497 1502 1497 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mef2a</italic>
###xml 1508 1513 1508 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1r</italic>
###xml 1664 1665 1664 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 221 226 <span type="species:ncbi:10090">mouse</span>
###xml 1267 1272 <span type="species:ncbi:10090">mouse</span>
###xml 1431 1435 <span type="species:ncbi:10090">mice</span>
###xml 1652 1656 <span type="species:ncbi:10090">mice</span>
Previous analysis of brain global gene expression in 5 TgPWS and 5 wildtype (WT) mice at P1 using a MG-U74Av2 gene chip array (Affymetrix) which assayed 12,000 genes and ESTs, demonstrated that all 4 paternally-expressed mouse PWS-region imprinted genes present on the array (Snurf-Snrpn, Ndn, Magel2 and Mkrn3) have dramatically reduced expression [15]. Additionally, mRNA levels for non-imprinted genes Herc2 and Cyfip1 were 50% in TgPWS compared with WT [15]. To assess the extent of the TgPWS/TgAS deletion and the potential effect of the transgene-insertion deletion on expression of flanking genes, we used data mining from several genome databases and analysis of several megabases of genome sequence to identify all genes in these regions, determined which of these were on the MG-U74Av2 gene chip, and then reanalyzed the brain microarray data from reference [15]. Although a 3-4 Mb "gene desert" lies just proximal of Tubgcp5, we identified 9 genes on the chip in the 9.1 Mb region centromeric of Tubgcp5, a locus which FISH data above had shown was deleted, of which four genes were not detectable in either TgPWS or WT brain at P1 (Table 1). Five genes (Gas2, Hrmt1l3, E2F8, Ptpn5, and Tsg101) were detectable and showed no change in TgPWS compared to WT mouse brain (Table 1), indicating that the TgPWS/TgAS deletion does not affect any of these genes (Fig. 1A). Telomeric of Frat3, an imprinted gene deleted in TgPWS mice [13], nine (Klf13, BB128963, Mcee, Apba2, Tjp1, Snrp2a, H47, Mef2a, and Igf1r) of the fourteen genes extending out a further 5.6 Mb and on the microarray were detectable and all had comparable levels in TgPWS and WT mice (Table 1). Therefore, the Tg insertion-induced deletion does not affect gene expression over large regions outside the boundaries of the rearrangement.
###end p 20
###begin p 21
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 65 67 65 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Brain microarray data for mouse chromosome 7B2-C genesa in TgPWS vs. WT mice.
###end p 21
###begin p 22
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snrpn</italic>
###xml 233 236 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Magel2</italic>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mkrn3 </italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ube3a</italic>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyfip1</italic>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Herc2</italic>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gabrb3</italic>
###xml 394 396 394 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 615 617 615 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
a The primary microarray data from this experiment were reported in reference 15. As summarized in Fig. 1A, reference 15 included the data for the imprinted genes within the TgPWS/TgAS deletion that are on the MG-U74Av2 chip (Snrpn, Ndn, Magel2, Mkrn3 and Ube3a) and for non-imprinted genes within the deletion (Cyfip1, Herc2, and Gabrb3, although the latter transcript was not detectable; the p gene is also represented on the chip although not detectable in TgPWS or WT mice, and not previously reported). Additionally, a cluster of chromosome 18B3 genes were found to be abnormally expressed in TgPWS mice [15]. b mRNA levels are presented as the medians of Signal (relative abundance of a transcript), for TgPWS (n = 5) and WT (n = 5), with the number of calls as "detected" out of 5 comparison experiments in parentheses.
###end p 22
###begin p 23
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 228 237 228 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 264 272 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5 </italic>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 468 477 468 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A,B</xref>
###xml 587 594 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec </italic>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 654 663 654 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 893 902 893 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
We next assessed quantitative (Q) expression of genes that map in the proximity of the known deleted loci at the centromeric [14,15] and telomeric [14] ends of the deletion (Fig. 1A). At the centromeric end of the deletion, the Siglec-H gene maps just proximal of Tubgcp5 and is predicted to have five exons (Fig. 1C), with the rare feature of having the stop codon in the penultimate exon 4 [19]. Since there is no information regarding the pattern of expression for Siglec-H [20,21], we first assessed this using RT-PCR (Fig. 3A,B). In agreement with the general signaling function of Siglec genes in the haemopoietic, immune and nervous systems [22], Siglec-H was predominantly expressed in brain and spleen (Fig. 3A). Less robust expression was seen in lung and skeletal muscle, while there was little or no amplification in heart, liver, kidney and testis (Fig. 3A). A postnatal role for Siglec-H expression was suggested by the lack of amplification at early embryonic stages with increased expression after birth (Fig. 3B), as also found for ESTs in Unigene (data not shown).
###end p 23
###begin p 24
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene expression analyses for loci at or near the TgPWS/TgAS deletion breakpoints</bold>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 82 115 82 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) Tissue expression of <italic>Siglec-H</italic></bold>
###xml 160 169 160 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 351 360 351 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNApolII </italic>
###xml 447 456 447 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 429 466 429 466 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) Developmental <italic>Siglec-H </italic>expression</bold>
###xml 487 496 487 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 607 615 607 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SiglecH </italic>
###xml 729 737 729 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2</italic>
###xml 754 763 754 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2 </italic>
###xml 771 778 771 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 670 778 670 778 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C-F) Relative quantification of brain mRNA levels for (C) <italic>Siglec-H</italic>, (D) <italic>Luzp2</italic>, (E) <italic>Cezanne2 </italic>and (F) <italic>Chrna7 </italic></bold>
###xml 990 992 988 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1005 1007 1001 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1022 1024 1016 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1152 1161 1144 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 1148 1161 1140 1153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) <italic>Siglec-H </italic></bold>
###xml 1247 1255 1239 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SiglecH </italic>
###xml 1276 1278 1268 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1302 1304 1292 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1321 1323 1309 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1369 1371 1353 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1407 1416 1391 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 1496 1498 1476 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1561 1563 1537 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1578 1584 1554 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1574 1584 1550 1560 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) <italic>Luzp2 </italic></bold>
###xml 1605 1607 1581 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1631 1633 1605 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1650 1652 1622 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1679 1681 1649 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1698 1700 1666 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1744 1746 1712 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1788 1790 1754 1756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1807 1809 1771 1773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1840 1842 1802 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1859 1861 1819 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1880 1889 1840 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2 </italic>
###xml 1876 1889 1836 1849 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) <italic>Cezanne2 </italic></bold>
###xml 2001 2003 1959 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2026 2028 1982 1984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2062 2064 2016 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2088 2090 2040 2042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2106 2114 2058 2066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ezanne2 </italic>
###xml 2155 2157 2105 2107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2181 2183 2129 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2217 2219 2163 2165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2243 2245 2187 2189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2257 2264 2201 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 2253 2264 2197 2208 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) <italic>Chrna7 </italic></bold>
###xml 2388 2390 2330 2332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2413 2415 2353 2355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2450 2452 2388 2390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2474 2476 2410 2412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2513 2520 2449 2456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 2549 2551 2483 2485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2575 2577 2507 2509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2614 2616 2544 2546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2640 2642 2568 2570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 1751 1755 <span type="species:ncbi:10090">mice</span>
###xml 1947 1951 <span type="species:ncbi:10090">mice</span>
###xml 2325 2330 <span type="species:ncbi:10090">mouse</span>
Gene expression analyses for loci at or near the TgPWS/TgAS deletion breakpoints. (A) Tissue expression of Siglec-H. RT-PCR using a cDNA mouse panel shows that Siglec-H (143-bp band) is strongly expressed in adult brain and spleen, with moderate expression in lung and skeletal muscle tissues, but is low or absent in heart, liver, kidney and testis. RNApolII (167-bp) gene expression was used as a control for both (A) and (B). (B) Developmental Siglec-H expression. Very low or absent Siglec-H expression is detected by RT-PCR at E7-E15 with weak expression at late gestational stages (E17). After birth, SiglecH expression is robustly detected in brain at P1 and P4. (C-F) Relative quantification of brain mRNA levels for (C) Siglec-H, (D) Luzp2, (E) Cezanne2 and (F) Chrna7 was performed by QRT-PCR in two groups of 5 TgPWS (black bars) or 5 TgAS (gray bars) and 5 WT (white bars) mice at P1 and in 4 TgPWS or 4 TgAS and 4 WT mice at P4. All values are presented as the means +/- SE: * P </= 0.05; ** P </= 0.001; *** P </= 0.0001, significant differences between WT and TgPWS or TgAS at the indicated time points (Independent samples t-test). (C) Siglec-H mRNA levels are decreased by ~2-fold in TgPWS and TgAS compared with WT at P1 and P4. SiglecH mRNA levels in TgPWS vs. WT were 0.52 +/- 0.04 vs. 1.29 +/- 0.15 (P = 0.002) and 0.56 +/- 0.12 vs. 1.31 +/- 0.19 (P = 0.01) at P1 and P4, respectively. Siglec-H mRNA levels were 0.45 +/- 0.03 in TgAS compared with 1.18 +/- 0.08 in WT at P1 (P = 0.0002) and 0.39 +/- 0.04 compared with 0.92 +/- 0.07 at P4 (P = 0.0008). (D) Luzp2 mRNA levels in TgPWS vs. WT were 0.98 +/- 0.02 vs. 1.25 +/- 0.07 (P = 0.009) and 0.91 +/- 0.02 vs. 1.11 +/- 0.05 (P = 0.01) at P1 and P4, respectively. In TgAS vs. WT mice, mRNA levels were 0.97 +/- 0.07 vs. 1.06 +/- 0.05 (P = 0.3) at P1 and 0.81 +/- 0.05 vs. 0.98 +/- 0.02 (P = 0.01) at P4. (E) Cezanne2 shows no difference in expression in TgPWS or TgAS and WT mice. At P1, mRNA levels were 1.01 +/- 0.03 for TgPWS vs. 1.04 +/- 0.1 for WT (P = 0.8) and 1.03 +/- 0.09 for TgAS vs. 1.06 +/- 0.03 for WT (P = 0.7). At P4, Cezanne2 mRNA levels were 0.92 +/- 0.08 for TgPWS vs. 1.04 +/- 0.03 for WT (P = 0.2) and 0.97 +/- 0.23 for TgAS vs. 1.09 +/- 0.06 for WT (P = 0.6). (F) Chrna7 mRNA levels are ~0.6-fold in TgPWS and TgAS compared with WT mouse brain. At P1 the mRNA levels were 0.64 +/- 0.04 in TgPWS vs. 0.99 +/- 0.08 in WT (P = 0.005) and 0.57 +/- 0.02 in TgAS vs. 0.89 +/- 0.1 in WT (P = 0.01), while at P4 mRNA levels for Chrna7 were 0.58 +/- 0.01 for TgPWS vs. 1.05 +/- 0.03 for WT (P < 0.0001) and 0.63 +/- 0.04 for TgAS vs. 1.08 +/- 0.12 for WT (P = 0.005).
###end p 24
###begin p 25
###xml 12 21 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 120 122 120 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 333 342 333 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2</italic>
###xml 502 504 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 538 544 538 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 590 592 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 598 600 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 672 678 672 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 741 743 741 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 791 797 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 958 964 958 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
By QRT-PCR, Siglec-H showed 2-fold decreased mRNA levels in the brain of both TgPWS and TgAS mouse models at P1 and P4 (P < 0.01; Fig. 3C), indicating that this gene appears to be within the TgPWS/TgAS deletion (Fig. 1A). It may also be noted that the 0.5-fold expression level in TgPWS and TgAS mice compared with WT indicates that Siglec-H is not an imprinted gene. The next gene centromeric of this, Luzp2, showed ~0.8-fold decreased mRNA levels in TgPWS brain at P1 and P4 and in TgAS brain at P4 (P < 0.05) (Fig. 3D). At P1 in TgAS, Luzp2 brain mRNA levels were decreased to 0.91-fold vs. WT (P = 0.3). Combined, the presence of the TgPWS/TgAS deletion resulted in a Luzp2 mRNA level in neonatal brain that is significantly (0.83-fold, P = 0.0002) less than in WT. We conclude that the Luzp2 gene is intact at the centromeric end of the TgPWS/TgAS deletion but suggest a model in which a neuronal regulatory element is deleted that accounts for ~33% of Luzp2 expression from the deleted allele (see Discussion for a description of this and alternative models).
###end p 25
###begin p 26
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2</italic>
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf13 </italic>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 293 302 293 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2 </italic>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3 </italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 456 463 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 530 537 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 605 612 605 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 667 669 667 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 708 715 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 944 951 944 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1073 1080 1073 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in cis </italic>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 1028 1033 <span type="species:ncbi:10090">mouse</span>
At the telomeric end of the deletion, expression of Cezanne2, which maps just centromeric of Klf13 (Fig. 1D), was unchanged by QRT-PCR in TgPWS and TgAS brain compared with WT mice (Fig. 3E), and thus this gene is intact in the TgPWS/TgAS deletion mouse model. The only remaining gene between Cezanne2 (intact in TgPWS/TgAS mice) and Frat3 (deleted [13]) is Chrna7 (Fig. 1D), suggesting that the deletion breakpoint might lie in the vicinity of this gene. Chrna7 is orientated with a telomeric 5' end (Fig. 1D). Using QRT-PCR for Chrna7 and primers spanning exon 2 to exon 3, we found ~1.7-fold decreased Chrna7 mRNA levels in both TgPWS and TgAS brain at P1 and P4 (P < 0.05) (Fig. 3F). Since the 5' end of Chrna7 is not deleted in the TgPWS/TgAS mouse model (see below, which is also consistent with the normal FISH signal for BAC RP23-16A4 reported above), the finding of ~60% total mRNA levels suggests that only ~20% of the usual level of Chrna7 mRNA transcripts are generated from the deleted chromosome in TgPWS and TgAS mouse brain. The 80% reduction in expression in cis suggests that the deletion removes essential regulatory sequences (see Discussion).
###end p 26
###begin title 27
Fine-mapping of the centromeric TgPWS/TgAS deletion breakpoint
###end title 27
###begin p 28
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 420 429 420 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 765 766 765 766 <underline xmlns:xlink="http://www.w3.org/1999/xlink">n</underline>
###xml 769 770 769 770 <underline xmlns:xlink="http://www.w3.org/1999/xlink">c</underline>
###xml 776 777 776 777 <underline xmlns:xlink="http://www.w3.org/1999/xlink">c</underline>
###xml 786 787 786 787 <underline xmlns:xlink="http://www.w3.org/1999/xlink">s</underline>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1087 1093 1087 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LUZP2 </italic>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1204 1209 1204 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LUZP2</italic>
###xml 1330 1334 1330 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gas2</italic>
###xml 1353 1359 1353 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1429 1431 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1511 1519 1511 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 997 1002 <span type="species:ncbi:9606">human</span>
###xml 1024 1029 <span type="species:ncbi:10090">mouse</span>
###xml 1057 1062 <span type="species:ncbi:9606">human</span>
###xml 1417 1422 <span type="species:ncbi:9606">human</span>
###xml 1445 1450 <span type="species:ncbi:9606">human</span>
The gene expression data described above suggest that Siglec-H is deleted in TgPWS and TgAS mice while Luzp2 is intact but shows slightly yet significantly reduced expression levels. In order to further delineate the centromeric breakpoint of the deletion and a potential mechanism for the ~33% reduction in Luzp2 expression from the deletion allele, we examined the genome sequence of BAC RP24-426A19 that lies between Siglec-H and Luzp2 (Fig. 1C) and that was identified above by FISH as partially deleted in TgPWS/TgAS mice. There are no exons for any gene encoded in this BAC. Nevertheless, using BLAST of RepeatMasked RP24-426A19 DNA sequence against the non-redundant GenBank database, extending from the centromeric end of BAC RP24-426A19 we identified five non-coding conserved sequences (NCCS1-5) at positions ~30.1, 39.9, 68.8, 107.3, and 134.5 kb, respectively (Fig. 1C). NCCS1-5 are 250-bp, 68-bp, 188-bp, 104-bp, and 157-bp in length and show 82%, 91%, 81%, 82% and 83% identity with human, respectively. As in mouse, the five NCCS elements in human are located adjacent to LUZP2 and map in chromosome 11p14.3 (Fig. 1B). All five NCCS elements are likely to be involved in the regulation of LUZP2, while other flanking genes are unlikely to be regulated by or to relate to NCCS1-5, as the next most centromeric gene (Gas2) maps 3.2 Mb from Luzp2 while the genes more telomeric are either non-syntenic in human (Fig. 1B), mapping to human chromosome 15q, or represent a rodent-specific acquisition (Siglec-H; see Discussion).
###end p 28
###begin p 29
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 280 292 280 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn </italic>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 388 393 388 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A,4B</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 632 634 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
PCR primers were designed from four of the NCCS elements and Q-PCR of DNA from TgPWS and WT mice was used to examine the relative amount of each NCCS with respect to intron 1 of Gapdh, which is intact in all mice studied. As a deletion control, we similarly examined by Q-PCR the Snurf-Snrpn promoter, which as expected showed a 0.4 to 0.44-fold relative level in TgPWS vs. WT mice (Fig. 4A,4B). Whereas there was no difference between TgPWS and WT mice for NCCS1 and NCCS3 (Fig. 4A), indicating that NCCS1, NCCS2 and NCCS3 are intact in TgPWS mice, Q-PCR for NCCS4 and NCCS5 identified 1.8-fold and 2.1-fold lower levels for TgPWS vs. WT, respectively (Fig. 4B), indicating that these are deleted from one allele in TgPWS mice. Therefore, the centromeric breakpoint of the TgPWS/TgAS ~5 Mb deletion lies in the 38.5 kb region between NCCS3 and NCCS4.
###end p 29
###begin p 30
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping of centromeric and telomeric TgPWS/TgAS deletion breakpoints and tissue specific up-regulation of <italic>Chrna7</italic></bold>
###xml 132 144 132 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn </italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 114 196 114 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) Q-PCR for the <italic>Snurf-Snrpn </italic>promoter, NCCS1 and NCCS3 relative to <italic>Gapdh </italic>intron 1</bold>
###xml 212 224 212 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn </italic>
###xml 308 310 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 363 365 357 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 391 393 383 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 488 490 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 540 546 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 498 554 486 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) Q-PCR for NCCS4 and NCCS5 relative to <italic>Gapdh </italic>intron 1</bold>
###xml 556 568 544 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn </italic>
###xml 604 606 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 633 635 617 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 727 729 707 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 813 815 789 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 827 834 803 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 823 891 799 867 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) <italic>Chrna7 </italic>expression (207-bp) is dramatically upregulated in liver </bold>
###xml 948 957 924 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNApolII </italic>
###xml 1062 1069 1038 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1020 1087 996 1063 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) Relative quantification by QRT-PCR of <italic>Chrna7 </italic>liver mRNA levels </bold>
###xml 1149 1151 1123 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1196 1203 1170 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1345 1347 1315 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1377 1384 1347 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1356 1410 1326 1380 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) Up-regulation of <italic>Chrna7 </italic>expression in TgAS spleen </bold>
###xml 1448 1455 1418 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1495 1497 1465 1466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</sub>
###xml 1444 1519 1414 1488 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) <italic>Chrna7 </italic>is normally expressed in P1 liver from E<sub>&#956;</sub>LMP2A transgenic mice </bold>
###xml 1549 1555 1518 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 1556 1562 1525 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 1543 1619 1512 1588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) A <italic>Chrna7</italic>-<italic>LMP2A </italic>fusion transcript is identified by RT-PCR in TgPWS brain </bold>
###xml 1682 1688 1651 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 1689 1695 1658 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 1658 1706 1627 1675 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) DNA sequence of the <italic>Chrna7</italic>-<italic>LMP2A </italic>fusion cDNA</bold>
###xml 1766 1773 1735 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1803 1809 1772 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 1900 1906 1869 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1503 1518 <span type="species:ncbi:10090">transgenic mice</span>
Mapping of centromeric and telomeric TgPWS/TgAS deletion breakpoints and tissue specific up-regulation of Chrna7. (A) Q-PCR for the Snurf-Snrpn promoter, NCCS1 and NCCS3 relative to Gapdh intron 1. The amount of Snurf-Snrpn DNA was 1.01 +/- 0.01 for the WT compared with 0.40 +/- 0.05 for the TgPWS samples, P = 0.006. For NCCS1, DNA fold was 0.98 +/- 0.02 in WT vs. 1.12 +/- 0.30 in TgPWS, P = 0.68. For NCCS3, DNA fold was 0.90 +/- 0.09 in WT compared with 1.09 +/- 0.03 in TgPWS mice, P = 0.20. (B) Q-PCR for NCCS4 and NCCS5 relative to Gapdh intron 1. Snurf-Snrpn DNA-fold was 0.40 +/- 0.07 in TgPWS vs. 0.90 +/- 0.1 in WT mice, P = 0.02. The amount of DNA for NCCS4 was 0.50 +/- 0.05 in TgPWS and 0.90 +/- 0.1 in WT mice, P = 0.05. For NCCS5, DNA-fold was 0.45 +/- 0.1 in TgPWS and 0.94 +/- 0.06 in WT mice, P = 0.05. (C) Chrna7 expression (207-bp) is dramatically upregulated in liver of TgPWS and TgAS at P1 compared with WT mice by RT-PCR. RNApolII expression (167-bp) was used as a control in (C), (E) and (F). (D) Relative quantification by QRT-PCR of Chrna7 liver mRNA levels shows a >/=15-fold increased expression in TgPWS (black bars) vs. WT (open bars) mice. Individual values for Chrna7 mRNA expression of 4 TgPWS and 4 WT mice at P1 are shown. The average mRNA expression was 40.76 +/- 14.30 for TgPWS and 2.70 +/- 3.21 for WT, P = 0.002. (E) Up-regulation of Chrna7 expression in TgAS spleen compared with WT at P1 by RT-PCR. (F) Chrna7 is normally expressed in P1 liver from EmuLMP2A transgenic mice compared with WT liver. (G) A Chrna7-LMP2A fusion transcript is identified by RT-PCR in TgPWS brain (lanes 1,2) but not in WT (lanes 3,4). (H) DNA sequence of the Chrna7-LMP2A fusion cDNA. Vertical lines mark the limit between exons 2, 3 and 4 of Chrna7 (bold font) and the 5' end of LMP2A sequence, while the 22-nt in italics is a transgene-specific sequence at the 5' end of the LMP2A exon.
###end p 30
###begin title 31
Up-regulation of Chrna7 allows mapping the telomeric TgPWS/TgAS deletion breakpoint
###end title 31
###begin p 32
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 454 456 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</sub>
###xml 509 515 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 543 550 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 573 575 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 616 622 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 654 660 653 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 702 717 701 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 in trans</italic>
###xml 765 772 764 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 841 845 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 914 920 913 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 1019 1020 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1021 1023 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1130 1137 1129 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
In contrast to the results shown above for Chrna7 expression in brain, regular RT-PCR for Chrna7 in newborn liver showed a dramatic increased expression in TgPWS and TgAS compared with WT (Fig. 4C). Indeed, quantification of liver Chrna7 expression by QRT-PCR revealed ~15-fold increased mRNA levels in TgPWS mice (P = 0.002) (Fig. 4D). A similar up-regulation of Chrna7 expression was found by RT-PCR in spleen tissues of TgAS mice (Fig. 4E). However, EmuLMP2A control mice with B-cell lineage expression of LMP2A showed normal expression of Chrna7 in newborn liver (Fig. 4F). Combined, these data on two different LMP2A transgene models indicates that LMP2A expression in B cells does not upregulate Chrna7 in trans, and suggests that the increased expression of Chrna7 observed in liver and spleen from TgPWS and TgAS mice results from a cis effect of the transgene insertion. Since B-cell transcription of the LMP2A transgene in these models is driven from an immunoglobulin heavy chain gene promoter and enhancer [7,16], we hypothesized that the latter enhancer was also driving transcription of the heterologous, endogenous Chrna7 promoter.
###end p 32
###begin p 33
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 165 167 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 391 397 391 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 604 611 604 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 816 823 816 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
To test this hypothesis, we used an exon 2 forward primer for Chrna7 and a reverse primer (OL-105) from inside the Tg (Fig. 5A) to perform RT-PCR on cDNA from TgPWS vs. WT brain, which detected a 1.1 kb product specifically in TgPWS samples (Fig. 4G). The 1.1 kb band was cloned and sequenced, identifying it as a fusion transcript encoding Chrna7 exons 2-4 fused to the sense strand of the LMP2A transgene (Fig. 4H). The latter result indicates that at least the telomeric copy of the Tg array is orientated in a 5'-3' telomere to centromere fashion. Furthermore, we can conclude that the 5' end of the Chrna7 locus is intact and correctly splices through exon 4 but then splices into the LMP2A transgene. These data strongly suggest that the telomeric breakpoint of the TgPWS/TgAS ~5 Mb deletion is in the 38.1 kb Chrna7 intron 4.
###end p 33
###begin p 34
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Orientation of the <italic>LMP2A </italic>transgene array</bold>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 42 71 42 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) <italic>LMP2A </italic>transgene structure</bold>
###xml 149 155 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 145 179 145 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) <italic>LMP2A </italic>transgene amplification </bold>
###xml 301 307 301 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C-D) </bold>
###xml 318 322 318 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 332 336 332 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
Orientation of the LMP2A transgene array. (A) LMP2A transgene structure. Restriction enzyme sites and primer location and orientation are shown. (B) LMP2A transgene amplification in TgPWS brain (Br) and liver (Li) (lanes 2,4) using primers RN1316 and RN1317 compared with the WT controls (lanes 3,5). (C-D) The use of (C) RN1316 or (D) RN1317 alone fails to generate PCR products in TgPWS and WT brain and liver.
###end p 34
###begin title 35
Orientation of the LMP2A transgene array
###end title 35
###begin p 36
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C,D</xref>
###xml 644 650 644 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 856 863 856 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 867 873 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
To fully understand how the transgene array might affect flanking gene expression, it is necessary to define the integrity of the array and the orientation of each transgene copy and to flanking genes. To characterize the transgene array, we amplified genomic DNA from TgPWS mice and WT controls using primers from within the transgene (Fig. 5A). Amplification with either single primer (RN1316 or RN1317) did not lead to any product (Fig. 5C,D), indicating that there are no head-to-head or tail-to-tail copies of adjacent transgene inserts. In contrast, PCR using primers from adjacent copies of the transgene results in amplification of the LMP2A array in TgPWS DNA (Fig. 5B). These data indicate that the ~80 copies of the transgene [7] are all in the same tail-to-head orientation. Combined with the data described above on the sense strand fusion of Chrna7 and LMP2A cDNA sequences, we conclude that the entire Tg array is orientated in a 5'-3' manner from the telomeric to centromeric end.
###end p 36
###begin title 37
Discussion
###end title 37
###begin title 38
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model of PWS/AS class I deletions
###end title 38
###begin p 39
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 370 379 370 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 382 389 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 996 1002 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gabrb3</italic>
###xml 1004 1010 1004 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gabra5</italic>
###xml 1012 1018 1012 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gabrg3</italic>
###xml 1020 1021 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1022 1026 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oca2</italic>
###xml 1032 1037 1032 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Herc2</italic>
###xml 1077 1082 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nipa1</italic>
###xml 1084 1089 1084 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nipa2</italic>
###xml 1091 1098 1091 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyfip1 </italic>
###xml 1102 1109 1102 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5</italic>
###xml 1178 1179 1178 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1180 1181 1180 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1435 1437 1435 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1470 1472 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1473 1475 1473 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1609 1610 1609 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1611 1612 1611 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1617 1623 1617 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ube3a </italic>
###xml 1641 1643 1641 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1644 1646 1644 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 734 739 <span type="species:ncbi:10090">mouse</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
###xml 1153 1158 <span type="species:ncbi:9606">human</span>
###xml 1402 1410 <span type="species:ncbi:9606">patients</span>
###xml 1443 1451 <span type="species:ncbi:9606">patients</span>
###xml 1506 1511 <span type="species:ncbi:10090">mouse</span>
###xml 1648 1653 <span type="species:ncbi:10090">mouse</span>
The TgPWS and TgAS mouse models were created by insertion of an LMP2A transgene array of ~80 copies [7] that fortuitously generated a deletion equivalent to those that occur in PWS and AS in the human. Although the mouse deletion was previously estimated as being ~5 Mb in length, genome sequence analysis indicates that the deleted segment could be as large as 6.8 Mb (Siglec-H to Chrna7 distance). However, there are a few gaps in the sequence, particularly in several duplicated genomic regions throughout the imprinted domain, and so the exact size of this interval remains unknown. Nevertheless, our previous [7,13-15] and present studies allow the conclusion that 13 imprinted and 11 non-imprinted genes are included within the mouse PWS/AS-deletion region (see Fig. 1A). In addition to spanning all the PWS- and AS-homologous paternally and maternally expressed genes, respectively, the TgPWS/TgAS deletion in mice also includes the homologs of typically deleted non-imprinted genes (ie., Gabrb3, Gabra5, Gabrg3, p/Oca2, and Herc2) as well as those of the PWS/AS genes (Nipa1, Nipa2, Cyfip1 and Tubgcp5) that define the deletion as equivalent to human class I deletions [1,4]. Although the classic PWS or AS clinical phenotype is similar in both class I and class II deletions, respectively, a more severe neurobehavioral phenotype has been described for class I compared with class II deletion patients as well as for deletion vs. UPD patients in each syndrome [23,24]. The TgPWS and TgAS deletion mouse models may therefore prove useful to compare the neurobehavioral phenotype to the UPD or ID PWS [5,6] or Ube3a gene mutation AS [11,12] mouse models.
###end p 39
###begin p 40
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 287 296 287 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 658 664 658 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 719 726 719 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 919 926 919 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 946 953 946 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1017 1023 1017 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1089 1091 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
Although the TgPWS/TgAS mouse models show reduced expression of several other genes, including Siglec-H, Luzp2 and Chrna7, as compared to the human PWS and AS class I deletions, none of these additional genes are likely to contribute to the TgPWS and TgAS phenotypes. For example, since Siglec-H is a recent evolutionary addition in the rodent genome [20], its 50% reduction in expression levels due to hemizygosity at the centromeric end of the deletion is unlikely to have a phenotypic effect. Likewise, the ~17% reduction in overall expression of Luzp2 observed in brain of TgPWS/TgAS mice is unlikely to be functionally important, since complete loss of Luzp2 does not lead to any specific phenotype [25]. Although Chrna7 is another gene partially deleted in TgPWS/TgAS mice and the human ortholog maps in 15q13, the latter is outside the PWS/AS deletions and the TgPWS/TgAS phenotype is unlikely to be affected by Chrna7 hemizygosity, since Chrna7 heterozygous knockout mice show no abnormal phenotypes and even Chrna7-/- null mice have only mild skin and reproductive phenotypes [26-29].
###end p 40
###begin title 41
Implications for evolutionary acquisition of new genes and breakpoint mechanisms
###end title 41
###begin p 42
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec </italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD33 </italic>
###xml 296 304 296 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-3</italic>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 422 430 422 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 793 800 793 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec </italic>
###xml 848 857 848 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 990 999 990 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 1070 1075 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2</italic>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1101 1108 1101 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5</italic>
###xml 1110 1116 1110 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyfip1</italic>
###xml 1118 1123 1118 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nipa2</italic>
###xml 1125 1130 1125 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nipa1</italic>
###xml 1133 1135 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1201 1210 1201 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
Our study also characterized expression of a recently identified gene, Siglec-H, which belongs to the Siglec gene family encoding immunoglobulin-like lectins that act as extracellular receptors for sialic acid residues of glycan chains [20,21]. The majority of Siglec genes map in a single CD33 (Siglec-3)-related cluster in human 19q13 and the syntenic mouse chromosome 7B2 region [20,21]. In contrast, we show here that Siglec-H, which is rodent-specific and has no primate ortholog [21], lies adjacent to the mouse PWS/AS-homologous region at a position 12.3 Mb from its ancestral location. It seems likely that Siglec-H has similar postnatal immunological functions as other Siglecs, given its robust expression in spleen. However, in contrast with the restricted expression of most other Siglec genes to the haematopoietic and immune systems, Siglec-H is also transcribed at high levels in postnatal brain. Although conjectural, it is tempting to speculate that neuronal expression of Siglec-H may have arisen due to an evolutionary positioning adjacent to single (Luzp2) [25] or clustered (ie., Tubgcp5, Cyfip1, Nipa2, Nipa1) [14] genes expressed at high levels in the nervous system, such that Siglec-H transcription may be under control of a neuronal enhancer for one or more of these genes.
###end p 42
###begin p 43
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 493 502 493 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 510 518 510 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5 </italic>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 659 667 659 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUBGCP5 </italic>
###xml 768 776 768 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUBGCP5 </italic>
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYFIP1</italic>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NIPA2</italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NIPA1</italic>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HERC2</italic>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 931 938 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1277 1283 1277 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3 </italic>
###xml 1303 1305 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1314 1319 1314 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HERC2</italic>
###xml 1357 1358 1357 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1475 1477 1475 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1478 1480 1478 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1481 1483 1481 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 1064 1069 <span type="species:ncbi:9606">human</span>
###xml 1235 1240 <span type="species:ncbi:10090">mouse</span>
###xml 1245 1250 <span type="species:ncbi:9606">human</span>
Intriguingly, both the centromeric and telomeric TgPWS/TgAS deletion breakpoints map at or close to the positions of chromosomal evolutionary breakpoints, and at each of the latter two positions there are also rodent-specific gene duplication-insertions. At the centromeric end, the TgPWS/TgAS deletion breakpoint lies immediately adjacent to Siglec-H, which as discussed above arose in rodents by a genomic duplication from a precursor gene located ~12 Mb away. The evolutionary insertion of Siglec-H between Tubgcp5 and Luzp2 occurs right at the boundary of synteny with human chromosome 15q11.2-q13 and 11p14.3-p15.1, respectively (Fig. 1B). Moreover, the TUBGCP5 ortholog also lies within a few kilobases of a primate evolutionary breakpoint that translocated the TUBGCP5 - CYFIP1-NIPA2-NIPA1-HERC2-duplicon cluster to 15q11.2 from an ancestral 15q13 location [14]. Although the telomeric TgPWS/TgAS deletion breakpoint within Chrna7 is not right at an evolutionary breakpoint, this gene also lies adjacent to an evolutionary breakpoint separating genes whose human orthologs map to the PWS imprinted domain in 15q11.2 and a point 8.7 Mb away in 15q13.3 (Fig. 1B). At this position also, there are species-specific duplications in mouse and human, with the retrotransposed Frat3 limited to rodents [13] or the HERC2- and flanking duplicons in primates [5,14]. Other authors have also noted the apparent congruity of chromosome rearrangement and evolutionary breakpoints [14,30-32], suggesting that currently unknown chromosomal structural features in these regions may play recombinogenic roles.
###end p 43
###begin title 44
Effect of the transgene or deletion on gene expression: mapping of putative neuronal enhancers
###end title 44
###begin p 45
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 757 763 757 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 809 815 809 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 1023 1029 1023 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1051 1058 1051 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in cis </italic>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1304 1310 1304 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 1335 1341 1335 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1517 1523 1517 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1614 1616 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1987 1991 1987 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gas2</italic>
###xml 2047 2054 2047 2054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tubgcp5</italic>
###xml 2072 2080 2072 2080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 2097 2099 2097 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 2149 2151 2149 2151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2152 2154 2152 2154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2247 2249 2247 2249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 2250 2252 2250 2252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2262 2271 2262 2271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2275 2283 2275 2283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2292 2294 2292 2294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 2344 2349 2344 2349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2</italic>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1780 1784 <span type="species:ncbi:10090">mice</span>
###xml 1924 1929 <span type="species:ncbi:9606">human</span>
###xml 2023 2028 <span type="species:ncbi:10090">mouse</span>
###xml 2085 2090 <span type="species:ncbi:9606">human</span>
Transgene insertions may be accompanied by other chromosomal rearrangements such as deletions (this paper; [33]), duplications [34], inversions [35], translocations [36], or combinations of rearrangements [36,37]. These events can induce alterations of gene expression over large chromosomal regions [33], or the transgene itself can do so [38]. Extensive analysis of genes flanking the TgPWS/TgAS transgene insertion demonstrated no other rearrangements other than the PWS/AS-region deletion and that gene expression over large regions outside the immediate flanking genes was not affected. In contrast, expression from the first gene promoter outside either end of the transgene insertion-deletion was affected. For example, the 5' promoter and 3' end of Luzp2 are ~600 kb and 110-140 kb centromeric to the LMP2A transgene array-deletion breakpoint, respectively, and this gene shows a significantly reduced expression in TgPWS and TgAS mice. Although at present we cannot fully exclude three models that might lower the Luzp2 transcriptional level in cis in brain, which invoke either (i) a non-specific disruption of chromatin, (ii) a weak silencing effect from the transgene tandem array [45], or (iii) extended antisense transcripts from the transgene array given that the 5'-3' orientation of the LMP2A array is opposite to the Luzp2 direction of transcription, we feel that these are less likely than a fourth model that has additional experimental support. We propose that the 33% reduction in expression of Luzp2 from the deletion allele is most likely explained by deletion of a neuronal enhancer (Fig. 6A). Consistent with this model, we identified two NCCS elements (NCCS4 and NCCS5) conserved in all eutherian mammals sequenced to date and deleted in TgPWS and TgAS mice, that represent strong candidates to be the neuronal enhancer. As noted above, these elements map to the homologous chromosome location in human but are almost 4 Mb from the next most centromeric gene (Gas2) while other flanking genes in mouse are non-syntenic (Tubgcp5) or not present (Siglec-H) in human (Fig. 1B). Numerous NCCSs occur within mammalian genomes [39,40], and while the majority of these have no known function, many do act as enhancer elements [41-43]. Future in vitro and in vivo studies [44] will be able to examine this enhancer model for Luzp2.
###end p 45
###begin p 46
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Enhancer models for tissue-specific expression of <italic>Luzp2 </italic>and <italic>Chrna7</italic></bold>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 68 161 68 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) Deletion of a putative neuronal enhancer 3' of <italic>Luzp2 </italic>lowers expression levels of the gene</bold>
###xml 424 430 424 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 599 606 599 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in cis </italic>
###xml 651 657 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 538 690 538 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) Activation in TgPWS and TgAS mice of the <italic>Chrna7 </italic>promoter <italic>in cis </italic>by the immunoglobulin (Ig) enhancer from the <italic>LMP2A </italic>transgene active in B lymphocytes</bold>
###xml 819 826 819 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 863 870 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 841 921 841 921 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) Activation of the <italic>Chrna7 </italic>promoter in WT mice by a putative neuronal enhancer</bold>
###xml 1142 1149 1142 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1242 1249 1242 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1260 1266 1260 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in cis</italic>
###xml 1164 1266 1164 1266 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) Deletion of a neuronal enhancer in TgPWS and TgAS mice virtually silences <italic>Chrna7 </italic>expression <italic>in cis</italic></bold>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 1218 1222 <span type="species:ncbi:10090">mice</span>
Enhancer models for tissue-specific expression of Luzp2 and Chrna7. (A) Deletion of a putative neuronal enhancer 3' of Luzp2 lowers expression levels of the gene. Symbols are: white boxes, exons; grey vertical box, 3'-untranslated region (UTR); arrow, transcriptional orientation; zig-zag line, transgene insertion-deletion breakpoint; grey horizontal box, enhancer; dashed arrow, neuronal enhancer contributing ~33% to the Luzp2 allelic promoter activity; X, block to enhancer function. Only the first and last exons of Luzp2 are shown. (B) Activation in TgPWS and TgAS mice of the Chrna7 promoter in cis by the immunoglobulin (Ig) enhancer from the LMP2A transgene active in B lymphocytes. Symbols are as for Fig. 6A, except: grey vertical box, 5'-untranslated region (UTR); dashed arrow, Ig enhancer upregulation of Chrna7 transcription. (C) Activation of the Chrna7 promoter in WT mice by a putative neuronal enhancer. The location of the enhancer is drawn arbitrarily but must map 3' to the TgPWS/TgAS deletion breakpoint in intron 4. Symbols are as for Fig. 6B, except: dashed arrow, neuronal enhancer for upregulation (~80%) of normal Chrna7 transcription. (D) Deletion of a neuronal enhancer in TgPWS and TgAS mice virtually silences Chrna7 expression in cis. Symbols are as for Fig. 6A and 6C.
###end p 46
###begin p 47
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in cis </italic>
###xml 311 318 311 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9 </italic>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 538 545 538 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
At the telomeric end of the deletion, expression of Chrna7 was dramatically upregulated in liver and spleen, but not brain, due to a tissue-specific positional effect of the transgene. We propose that the transgene immunogobulin Mu enhancer acts in B cells to promote transcription in cis from the heterologous Chrna7 promoter (Fig. 6B). Similarly, transgene regulatory elements 1 Mb away have been shown to activate Sox9 [38]. Moreover, our data combined with cloning of a 5'-Chrna7-LMP2A fusion transcript clearly demonstrates that the Chrna7 promoter is intact and fully capable of high levels of enhancer driven activity on the deletion allele in TgPWS/TgAS mice.
###end p 47
###begin p 48
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 768 775 768 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 980 987 980 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1013 1020 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1141 1148 1141 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1222 1229 1222 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1492 1499 1492 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1508 1516 1508 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1598 1605 1598 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1756 1763 1756 1763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1899 1906 1899 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 2054 2061 2054 2061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 2124 2133 2124 2133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2137 2145 2137 2145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 659 664 <span type="species:ncbi:10090">mouse</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
###xml 1280 1284 <span type="species:ncbi:10090">mice</span>
###xml 1947 1952 <span type="species:ncbi:10090">mouse</span>
Perhaps the most intriguing finding of this study was our serendipitous discovery that a putative neuronal enhancer for the Chrna7 gene maps within the telomeric end of the TgPWS and TgAS deletion. In TgPWS and TgAS mice, the Chrna7 mRNA level in brain from the deletion chromosome 7 falls to 20% of normal levels despite the fact that the 5' promoter is not deleted. Non-enhancer models appear unlikely to explain this data: for example, models invoking (i) non-specific disruption of chromatin or (ii) a silencing effect from the transgene tandem array [45] are unlikely to account for the specific ~80% reduction in cis expression levels in TgPWS and TgAS mouse brain, while allowing a dramatic activation of the same promoter in immune tissues, and, finally (iii) Chrna7 is transcribed from upstream and in the same orientation as the transgene array, so that an antisense mechanism is not valid. Therefore, we propose that sequences that map 3' of the deletion breakpoint in Chrna7 intron 4 are critical for Chrna7 expression in neurons (Fig. 6C), and it is the deletion of this putative neuronal enhancer that accounts for the reduced Chrna7 expression in brain of TgPWS and TgAS mice (Fig. 6D). Similar analyses of Chrna7 gene expression in other tissues of TgPWS and TgAS mice, such as the neuromuscular junction, heart, and skin, will allow further assessment of the tissue specificity of the proposed enhancer. Interestingly, our data in brain and other tissues also imply that the Chrna7 promoter in vivo only has basal transcriptional activity whereas for high levels of transcription, Chrna7 requires activation by a tissue-specific enhancer(s). In support of this model, we recently identified as candidate enhancer elements two NCCSs within Chrna7 intron 4, whereas no other conserved non-coding sequences other than the minimal promoter occur in a 412 kb domain starting 18 kb 5' of Chrna7 and extending 3' of the gene towards the mouse PWS-region imprinted domain (R.D.N., K.C., and M.S., unpublished data). We are currently mapping the Chrna7 NCCS elements against the TgPWS/TgAS deletion endpoints, while in vitro and in vivo approaches will be needed for analysis of function as candidate neuronal transcriptional enhancers and/or for other cell types.
###end p 48
###begin title 49
Conclusion
###end title 49
###begin p 50
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 266 273 266 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 604 610 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2</italic>
###xml 952 958 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1185 1191 1185 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 1203 1210 1203 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA7 </italic>
###xml 1313 1315 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1412 1421 1412 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1456 1463 1456 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA7 </italic>
###xml 1464 1466 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1467 1469 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1525 1533 1525 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1534 1536 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1600 1615 1600 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 in vivo </italic>
###xml 1839 1846 1839 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA7 </italic>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 1196 1201 <span type="species:ncbi:9606">human</span>
###xml 1733 1738 <span type="species:ncbi:9606">human</span>
In this study, we used a variety of molecular cytological and genetic technologies to map the transgene insertion-chromosome deletion breakpoints of a mouse model of PWS and AS to ~38 kb regions between the Luzp2 and Siglec-H genes at the centromeric end and within Chrna7 intron 4 at the telomeric end, respectively. Gene expression analyses then allowed us to demonstrate that genes extending out a further 9.1- or 5.6-Mb centromeric or telomeric of the deletion, respectively, are not affected by either the deletion or insertion of the transgene tandem array. In contrast, transcription of genes at (Chrna7) or flanking (Luzp2) the transgene insertion-deletion breakpoints are affected by the disruption of normal chromosome architecture, with positional effects leading to up- or down-regulation dependent on the tissue-specificity and locations of enhancers within the transgene or putatively removed by the TgPWS/TgAS chromosome deletion. Using Luzp2 as an example, we demonstrate that analysis of phylogenetically conserved sequences and consideration of synteny allows the fine mapping of a putative neuronal enhancer element(s), while a similar model likely also applies for Chrna7. In human, CHRNA7 is of significant interest as a schizophrenia candidate gene with both genetic and functional support [46-48]. Nevertheless, the molecular basis of its candidacy remains uncertain since rare coding and in vitro characterized promoter variants in CHRNA7 [49,50] may be insufficient to account for deficient function in vivo [51], particularly in light of our observations that expression of Chrna7 in vivo requires a major participation of enhancer function. Identification of a neuronal enhancer and further studies in the human to examine for genetic variation and potential mutations might provide an explanation for a role of CHRNA7 as a schizophrenia-susceptibility gene.
###end p 50
###begin title 51
Methods
###end title 51
###begin title 52
Animals
###end title 52
###begin p 53
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 224 226 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</sub>
###xml 271 277 270 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 278 280 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 498 499 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 500 502 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
We used three mouse models all of which have an LMP2A transgene insertion. In the TgPWS and TgAS models, the insertion of an LMP2A transgene array replaced the PWS/AS-homologous region in chromosome 7B/C [7,9,15] while the EmuLMP2A mice have B-cell lineage expression of LMP2A [16]. WT littermates were used as controls in each experiment. The University of Pennsylvania Institutional Animal Care and Use Committee approved all animal experiments. All animals were bred and genotyped as described [7,16].
###end p 53
###begin title 54
BAC contig assembly and fluorescence in situ hybridization (FISH) studies
###end title 54
###begin p 55
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 662 667 <span type="species:ncbi:10090">mouse</span>
Splenocytes from TgAS mice were cultured for 48 hr in the presence of concanavalin A for stimulation of cell proliferation. After harvesting, cells were treated with hypotonic buffer (0.075 M KCl) for 15 min, chromosomes were fixed with methanol-acetic acid (3:1) and spread onto slides [17]. For some probes, fibroblast cell lines from TgPWS mice were used. BAC DNA was labeled with biotin or digoxigenin and hybridized as previously described [18]. Image acquisition was performed using fluorescence microscopy, acquiring grayscale images using separate filters for each fluorophore followed by digital merging and pseudocoloring. BAC RP22-434N7, spanning the mouse chromosome 7 tyrosinase gene, was used as a control probe to identify both chromosome 7 homologues.
###end p 55
###begin p 56
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 430 436 430 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trpm1 </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlsn1</italic>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
The chromosome 7B/C BAC contigs were generated by standard bioinformatics analyses using Ensembl [52] and BLAST [53]. The position and overlap of each BAC clone was determined by BLAST using gene cDNA/EST sequences, BAC end sequences, and STS sequences. Previously described BACs are RP23-266F22 [13], RP23-256L9, RP23-195C6, RP24-396N13 and RP24-354P8 [14]. It may be noted that we previously incorrectly assumed the position of Trpm1 (formerly Mlsn1) [7], whereas analysis of genomic sequence data now clearly place this locus telomeric to the TgPWS/TgAS deletion (see Fig. 1A).
###end p 56
###begin title 57
Gene expression analyses
###end title 57
###begin title 58
Microarray analysis
###end title 58
###begin p 59
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 110 116 <span type="species:ncbi:10090">Murine</span>
Brain global gene expression was assessed in five TgPWS and five WT male CD-1 sibs at P1 using the Affymetrix Murine Genome (MG) U74Av2 Array. The microarray experiments and data processing, with identification of genes significantly altered in TgPWS brain, were performed previously (see also Table 1) [15]. In the present study, we reanalyzed the microarray data for genes identified from bioinformatics analyses (see above) as mapping adjacent to the TgPWS/TgAS deletion.
###end p 59
###begin title 60
QRT-PCR
###end title 60
###begin p 61
###xml 134 141 134 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 504 510 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 717 719 717 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 810 812 810 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 862 871 862 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cezanne2 </italic>
###xml 969 976 969 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 1074 1080 1074 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 1182 1191 1182 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
Brain tissues from four or five each of TgPWS, TgAS and littermate WT mice at P1 and P4 were used for most QRT-PCR experiments. Liver Chrna7 expression was determined in four TgPWS and four WT mice at P1. QRT-PCR analysis was performed as described [15]. Briefly, total RNA was extracted using TRIzol (Invitrogen) and reverse-transcribed using Superscript First-Strand Synthesis System (Invitrogen). For all reactions, each sample was loaded in triplicate and SYBR green was used as the fluorescent dye. Gapdh was used as an internal control. Relative quantification of gene expression was carried out using a PRISM 7000 Sequence Detection System (Applied Biosystems Inc.) and data was processed using a comparative CT method [15]. A t-test for independent samples (Analyze-it) was used to generate two-tailed P statistics for each experiment. PCR primers were: Cezanne2 (exons 11-12): RN2262: 5'-TGATTCACAAGCTCCCCTAGCT-3' (F), RN2263: 5'-GGAGTGGACCTGGGTTCATCT-3' (R); Chrna7 (exons 2-3): RN2357: 5'-GCCGCTCACCGTGTACTTCT-3' (F), RN2358: 5'-GGTGGTTAAAACTTGGTTCTTCTCA-3' (R); Luzp2 (exons 7-8): RN2264: 5'-AAATCCAAGCCCAGCTGAAA-3' (F), RN2265: 5'-TGTTGGGCCTTAAATAACAAATCTT-3' (R); and Siglec-H (exons 1-2): RN2464: 5'-AGGATCTCTGTGCATGTGACAGA-3' (F), RN2465: 5'-AGGACGACCAAGCTCCAGTGT-3' (R).
###end p 61
###begin title 62
Regular RT-PCR
###end title 62
###begin p 63
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 66 68 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</sub>
###xml 118 125 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 171 173 170 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 284 291 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 385 394 384 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 521 530 520 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H </italic>
###xml 632 641 631 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNApolII </italic>
###xml 782 788 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7</italic>
###xml 790 798 789 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-H</italic>
###xml 804 813 803 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNApolII </italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 427 432 <span type="species:ncbi:10090">Mouse</span>
Liver expression of Chrna7 was assessed in 2 TgPWS, 2 TgAS and 2 EmuLMP2A mice and WT littermates at P1. In addition, Chrna7 expression in spleen was determined in 2 TgAS vs. 2 WT mice at P1. Extraction and reverse transcription of total RNA was performed as for QRT-PCR experiments. Chrna7 primers (exons 1-3) were: RN2368: 5'-GGAGGCATCTGGCTGGCTCTG-3' (F), and RN2358 (R; see above). Siglec-H expression was performed using a Mouse Multiple Tissue cDNA Panel I (BD Bioscience Clontech) as well as WT brain at P1 and P4. Siglec-H primers (exons 1-2) were RN2511: 5'-GTGACAACGGTTCTTACT-3' (F) and RN2465 (R). For each gene analysis, RNApolII expression was used as a control: RN2318: 5'-ACTCCTTCACTCACTGTCTTCCTGTT-3' (F), RN2319: 5'-TCCTGATCTTCTGCCACCACTGT-3'(R). PCR conditions for Chrna7, Siglec-H, and RNApolII were initial denaturation at 94degreesC, 10 min, followed by 32 cycles of denaturation at 94degreesC for 30 sec, annealing at 55degreesC, 30 sec, and extension at 72degreesC, 30 sec, with a final extension at 72degreesC, 10 min, using Gold Taq DNA polymerase (ABI).
###end p 63
###begin title 64
NCCS analysis at the centromeric TgPWS/TgAS deletion breakpoint
###end title 64
###begin p 65
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 720 726 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 845 857 845 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snurf-Snrpn </italic>
###xml 1026 1028 1026 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
We identified non-coding conserved sequences (NCCS) by taking BAC genomic sequence, masking repetitive sequences with RepeatMasker [54], then using BLAST analysis of the non-redundant (NR) and whole genome shotgun (wgs) databases. From BAC RP24-426A19, we identified five NCCS elements (see Results), and PCR primers for NCCS1, NCCS3, NCCS4 and NCCS5 were designed and used to quantify the DNA amount in WT and TgPWS mice by Q-PCR. Brain and liver DNA were extracted using a phenol-chloroform method. 500 ng of each DNA sample was used for Q-PCR and SYBR green was used as the fluorescent dye, with each Q-PCR reaction performed in triplicate. As an internal control for comparison of test DNA sequence, we used PCR for Gapdh intron 1: RN2518: 5'-GGCCGCCGCCATGT-3' (F) and RN2519: 5'-GGAAGGCCTAAGCAAGATTTCA-3' (R). In addition, primers from the Snurf-Snrpn promoter were used as a positive control for the deletion status in TgPWS DNA: RN2142: 5'-GCAAAAATGTGCGCATGTG-3' (F) and RN2143: 5'-CTCTCCTCTCTGCGCTAGTCTTG-3' (R). The CT method was used to process the data [15] and all the samples were normalized to the same WT sample. Primers for NCCS1 were: RN2515: 5'-AAATCATGAGCCAAGCCAAAA-3' (F) and RN2516: 5'-TGGCTTCCCTTATCACTTTCACA-3' (R); for NCCS3: RN2513: 5'-TTGGAACATGCAGAACAATGAAT-3' (F) and RN2514: 5'-AGGCTGCCAACCTGCAAA-3' (R); for NCCS4: RN2522: 5'-GCCACTAAATTGGATCCTTAGACATAT-3' (F) and RN2523: 5'-AAACCTGTTCCTACCCATGATAATCT-3' (R); and for NCCS5: RN2524: 5'-TCTCCCCCTAGGTCTTCTGTTTAA-3' (F) and RN2525: 5'-TGGCCAGTGATC ATGTACAGATC-3' (R).
###end p 65
###begin title 66
Fine mapping of the telomeric TgPWS/TgAS deletion breakpoint
###end title 66
###begin p 67
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna7 </italic>
###xml 644 648 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfx </italic>
To fine map the telomeric TgPWS/TgAS breakpoint, total RNA from TgPWS brain tissue was reverse-transcribed using the Superscript First-Strand Synthesis System (Invitrogen) with a reverse primer from inside the transgene (Fig. 5A): OL-105: 5'-CGTGTGGCTTAC CTGCTGCCAATG-3'. cDNA was amplified by PCR using the RN2357 forward primer for Chrna7 (exon 2) and OL-105. The amplification conditions were initial denaturation at 94degreesC for 10 min, followed by 37 cycles of denaturation at 94degreesC for 4 min, annealing at 61degreesC for 1 min, and extension at 72degreesC for 6 min, with a final extension at 72degreesC for 10 min, using Platinum Pfx DNA polymerase (Invitrogen). PCR products were cloned into the pCR2.1-TA vector using a TOPO TA cloning kit (Invitrogen) and sequenced using standard techniques (University of Pennsylvania DNA sequencing Core facility).
###end p 67
###begin title 68
Orientation of the LMP2A transgene
###end title 68
###begin p 69
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMP2A </italic>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 659 663 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
To determine the orientation of the LMP2A transgene array, three types of PCR amplifications were performed, first using forward and reverse primers located at the 3' and 5' ends of the transgene sequence, respectively (Fig. 5A): RN1316: 5'-GTTGTTTCCGCCATCGTACC-3' (R) and RN1317: 5'-TATGAGCTACTCTCTGACCC-3' (R). The other two reactions were performed using either forward or reverse primers alone. The amplification conditions were 95degreesC for 10 min followed by 32 cycles of denaturation at 95degreesC for 30 sec, annealing at 59degreesC for 30 sec, and extension at 72degreesC for 30 sec, with a final extension at 72degreesC for 10 min, using Platinum Taq Gold polymerase (ABI).
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
###xml 479 481 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</sub>
###xml 449 454 <span type="species:ncbi:10090">mouse</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
MS prepared tissue samples, performed PCR, RT-PCR, QRT-PCR and QPCR studies, microarray and genome sequence analyses and drafted the manuscript. KCC carried out some RT-PCR experiments and performed the identification of the telomeric deletion breakpoint and DNA sequence analyses. ES performed FISH studies. JHC contributed to BAC contig assembly. TO performed transgene array analyses and designed these experiments. RL established the transgenic mouse lines and provided the EmuLMP2A mouse tissues. JMG designed, supervised and interpreted the FISH experiments. RDN designed the study, coordinated the project, performed genome sequence analysis, BAC contig assembly, participated in drafting and edited the manuscript.
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
###xml 99 101 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</sub>
###xml 107 122 <span type="species:ncbi:10090">transgenic mice</span>
We thank Brande Latney for technical assistance and Dr. Toni Portis for provision of tissues from EmuLMP2A transgenic mice. This work was funded by grants to R.D.N. from the National Institutes of Health (HD31491 and ES10631) and from the Foundation for Prader-Willi Research (FPWR). R.L. is supported by Public Health Service grants CA62234, CA73507, and CA93444 from the National Cancer Institute and DE13127 from the National Institute of Dental and Craniofacial Research. M.S. was supported by a fellowship from the American Heart Association.
###end p 73
###begin article-title 74
Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes
###end article-title 74
###begin article-title 75
Prader-Willi and Angelman syndromes. Disorders of genomic imprinting
###end article-title 75
###begin article-title 76
###xml 6 14 <span type="species:ncbi:9606">patients</span>
Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion
###end article-title 76
###begin article-title 77
Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints
###end article-title 77
###begin article-title 78
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snrpn </italic>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
A candidate mouse model for Prader-Willi syndrome which shows an absence of Snrpn expression
###end article-title 78
###begin article-title 79
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for Prader-Willi syndrome imprinting-centre mutations
###end article-title 79
###begin article-title 80
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and Angelman syndromes
###end article-title 80
###begin article-title 81
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models for Prader-Willi and Angelman syndromes offer insights into novel obesity mechanisms
###end article-title 81
###begin article-title 82
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Hormonal and metabolic defects in a Prader-Willi syndrome mouse model with neonatal failure to thrive
###end article-title 82
###begin article-title 83
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
A candidate model for Angelman syndrome in the mouse
###end article-title 83
###begin article-title 84
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation
###end article-title 84
###begin article-title 85
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ube3a </italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice
###end article-title 85
###begin article-title 86
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frat3 </italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Retrotransposed genes such as Frat3 in the mouse Chromosome 7C Prader-Willi syndrome region acquire the imprinted status of their insertion site
###end article-title 86
###begin article-title 87
Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons
###end article-title 87
###begin article-title 88
A nonimprinted Prader-Willi Syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted PWS loci do not alter genome-wide mRNA levels
###end article-title 88
###begin article-title 89
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
###end article-title 89
###begin article-title 90
Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing
###end article-title 90
###begin article-title 91
Conserved characteristics of heterochromatin-forming DNA at the 15q11-q13 imprinting center
###end article-title 91
###begin article-title 92
Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise
###end article-title 92
###begin article-title 93
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec</italic>
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSiglec-F</italic>
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siglec-3</italic>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 112 116 <span type="species:ncbi:9606">CD33</span>
Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters
###end article-title 93
###begin article-title 94
###xml 30 34 <span type="species:ncbi:9606">CD33</span>
Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms
###end article-title 94
###begin article-title 95
Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling
###end article-title 95
###begin article-title 96
Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy
###end article-title 96
###begin article-title 97
Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects
###end article-title 97
###begin article-title 98
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luzp2 </italic>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Cloning, functional study and comparative mapping of Luzp2 to mouse chromosome 7 and human chromosome 11p13-11p14
###end article-title 98
###begin article-title 99
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents
###end article-title 99
###begin article-title 100
Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium
###end article-title 100
###begin article-title 101
A phenotype for the alpha 7 nicotinic acetylcholine receptor null mutant
###end article-title 101
###begin article-title 102
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in CHRNA7, a subunit of the nicotinic acetylcholine receptor, produce sperm with impaired motility
###end article-title 102
###begin article-title 103
###xml 50 66 50 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gorilla gorilla </italic>
###xml 50 65 <span type="species:ncbi:9593">Gorilla gorilla</span>
###xml 167 172 <span type="species:ncbi:9606">human</span>
The evolutionary chromosome translocation 4;19 in Gorilla gorilla is associated with microduplication of the chromosome fragment syntenic to sequences surrounding the human proximal CMT1A-REP
###end article-title 103
###begin article-title 104
Hotspots of mammalian chromosomal evolution
###end article-title 104
###begin article-title 105
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gdf6 </italic>
Comparative sequence analysis of the Gdf6 locus reveals a duplicon-mediated chromosomal rearrangement in rodents and rapidly diverging coding and regulatory sequences
###end article-title 105
###begin article-title 106
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dkk1 </italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lrp6</italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6
###end article-title 106
###begin article-title 107
Exma: an X-linked insertional mutation that disrupts forebrain and eye development
###end article-title 107
###begin article-title 108
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
Genetic characterization of the chromosomal rearrangements that accompany the transgene insertion in the chakragati mouse mutant
###end article-title 108
###begin article-title 109
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dspd </italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
The novel dominant mutation Dspd leads to a severe spermiogenesis defect in mice
###end article-title 109
###begin article-title 110
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse
###end article-title 110
###begin article-title 111
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9 </italic>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Odd Sex </italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ods</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Long-range activation of Sox9 in Odd Sex (Ods) mice
###end article-title 111
###begin article-title 112
###xml 31 36 <span type="species:ncbi:9606">human</span>
Ultraconserved elements in the human genome
###end article-title 112
###begin article-title 113
Conserved non-genic sequences - an unexpected feature of mammalian genomes
###end article-title 113
###begin article-title 114
Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons
###end article-title 114
###begin article-title 115
###xml 9 14 <span type="species:ncbi:9606">human</span>
Scanning human gene deserts for long-range enhancers
###end article-title 115
###begin article-title 116
Comparative genomic analysis as a tool for biological discovery
###end article-title 116
###begin article-title 117
Analysis of vertebrate SCL loci identifies conserved enhancers
###end article-title 117
###begin article-title 118
Conspiracy of silence among repeated transgenes
###end article-title 118
###begin article-title 119
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
###end article-title 119
###begin article-title 120
Genetic linkage to schizophrenia at chromosome 15q14
###end article-title 120
###begin article-title 121
The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes
###end article-title 121
###begin article-title 122
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia
###end article-title 122
###begin article-title 123
Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects
###end article-title 123
###begin article-title 124
The promoter-194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit
###end article-title 124
###begin article-title 125
Website title
###end article-title 125
###begin article-title 126
Website title
###end article-title 126
###begin article-title 127
Website title
###end article-title 127

